Karen Katz - 31 Dec 2021 Form 4 Insider Report for HUMANA INC (HUM)

Role
Director
Signature
Karen W. Katz
Issuer symbol
HUM
Transactions as of
31 Dec 2021
Net transactions value
+$13,510
Form type
4
Filing time
04 Jan 2022, 08:00:19 UTC
Previous filing
19 Oct 2021
Next filing
05 Jan 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding HUM Humana Common 590 31 Dec 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HUM Restricted Stock Units Award $10,249 +22 +4.3% $465.85 535 31 Dec 2021 Humana Common 22 Direct F2
transaction HUM Restricted Stock Units Award $3,261 +7 +233% $465.85 10 31 Dec 2021 Humana Common 7 Direct F3
transaction HUM Restricted Stock Units Award $0 +412 $0.000000 412 03 Jan 2022 Humana Common 412 Direct F4
holding HUM Restricted Stock Units 856 31 Dec 2021 Humana Common 856 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Annual Director's fee payable in stock units, deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).
F2 Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).
F3 Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).
F4 Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/22.